This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOZIC, K. J.
Right arrow Articles by THORNHILL, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOZIC, K. J.
Right arrow Articles by THORNHILL, T. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery 81:200-209 (1999)
© 1999 The Journal of Bone and Joint Surgery, Inc.

Survivorship Analysis of Hips Treated with Core Decompression for Nontraumatic Osteonecrosis of the Femoral Head*

KEVIN J. BOZIC, M.D.{dagger}, DAVID ZURAKOWSKI, PH.D.{ddagger} and THOMAS S. THORNHILL, M.D.§, BOSTON, MASSACHUSETTS

Investigation performed at the Department of Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston

We reviewed the long-term results of core decompression for the treatment of nontraumatic osteonecrosis of the femoral head, performed in thirty-four patients (fifty-four hips) between January 1, 1981, and June 30, 1995. Twenty patients (59 percent) had bilateral involvement. The mean age of the patients at the time of presentation was thirty-eight years (range, twenty-two to eighty-three years). The presumed risk factors were use of corticosteroids (thirty-seven hips), excessive in take of alcohol (eight hips), and use of adrenocorticotropic hormone for the treatment of multiple sclerosis (two hips); the remaining seven hips had idiopathic osteonecrosis. According to a modification of the classification system of Ficat and Arlet in combination with the system of Steinberg et al., thirteen hips were stage I (normal radiographs) preoperatively; seven, stage IIA sclerotic; sixteen, stage IIA cystic or sclerocystic; ten, stage IIB (transitional stage, with a crescent sign); and eight, stage III (collapse). The mean duration of follow-up after the core decompression was 120 months (range, twenty-four to 196 months). The result was considered successful if the patient was asymptomatic, with no progression of the disease, and unsuccessful if there was radiographic failure (progression to stage III [collapse]) or clinical failure (the need for a subsequent operation), or both. The Kaplan-Meier product-limit method was used to estimate clinical and radiographic survival. Overall, twenty-six hips (48 percent) had a satisfactory clinical result and twenty (37 percent) survived according to radiographic criteria. Radiographic or clinical failure, or both, were seen in four of the thirteen stage-I hips, none of the seven stage-IIA sclerotic hips, thirteen of the sixteen stage-IIA cystic or sclerocystic hips, nine of the ten stage-IIB hips, and all eight stage-III hips. On the basis of the Cox proportional-hazards regression model, significant predictors of overall failure included an advanced preoperative radiographic stage (p < 0.0001), a shorter duration of symptoms (p < 0.05), and use of corticosteroids (p < 0.05). No association was found between age, gender, excessive intake of alcohol, or renal transplantation and the overall outcome. Two patients (two hips; 4 percent) had a postoperative complication. One patient had a fracture of the femoral neck, and the other had a hematoma. Our findings suggest that core decompression is a safe and effective procedure for the treatment of stage-I or stage-IIA sclerotic disease. These data also demonstrate the importance of differentiating between stage-IIA sclerotic disease and stage-IIA cystic or sclerocystic disease. We believe that core decompression has a limited role in the operative management of patients who have evidence of cystic changes in the femoral head on plain radiographs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
C. J.H. Veillette, H. Mehdian, E. H. Schemitsch, and M. D. McKee
Survivorship Analysis and Radiographic Outcome Following Tantalum Rod Insertion for Osteonecrosis of the Femoral Head
J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
T. F. Roush, S. A. Olson, R. Pietrobon, L. Braga, and J. R. Urbaniak
Influence of Acetabular Coverage on Hip Survival After Free Vascularized Fibular Grafting for Femoral Head Osteonecrosis
J. Bone Joint Surg. Am., October 1, 2006; 88(10): 2152 - 2158.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. A. Mont, L. C. Jones, and D. S. Hungerford
Nontraumatic Osteonecrosis of the Femoral Head: Ten Years Later
J. Bone Joint Surg. Am., May 1, 2006; 88(5): 1117 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. J. Karimova, S. N. Rai, D. Ingle, A. C. Ralph, X. Deng, M. D. Neel, S. C. Howard, C.-H. Pui, and S. C. Kaste
MRI of Knee Osteonecrosis in Children with Leukemia and Lymphoma: Part 2, Clinical and Imaging Patterns
Am. J. Roentgenol., February 1, 2006; 186(2): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
D. Marciniak, C. Furey, and J. W. Shaffer
Osteonecrosis of the Femoral Head. A Study of 101 Hips Treated with Vascularized Fibular Grafting
J. Bone Joint Surg. Am., April 1, 2005; 87(4): 742 - 747.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
K. R. Berend, E. E. Gunneson, and J. R. Urbaniak
Free Vascularized Fibular Grafting for the Treatment of Postcollapse Osteonecrosis of the Femoral Head
J. Bone Joint Surg. Am., May 28, 2003; 85(6): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. R. Lieberman, D. J. Berry, M. A. Montv, R. K. Aaron, J. J. Callaghan, A. Rayadhyaksha, and J. R. Urbaniak
Osteonecrosis of the Hip: Management in the Twenty-first Century
J. Bone Joint Surg. Am., May 1, 2002; 84(5): 834 - 853.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Torres, V. Lorenzo, and E. Salido
Calcium Metabolism and Skeletal Problems after Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 551 - 558.
[Full Text] [PDF]


Home page
JBJSHome page
M. Bhandari, G. H. Guyatt, and M. F. Swiontkowski
User's Guide to the Orthopaedic Literature: How to Use an Article About Prognosis
J. Bone Joint Surg. Am., October 1, 2001; 83(10): 1555 - 1564.
[Full Text] [PDF]


Home page
JBJSHome page
J. D. Witt and S. P. Scully
Age Bias and Choice of Intervention for Treatment of Avascular Necrosis
J. Bone Joint Surg. Am., December 1, 2000; 82(12): 1804-a - 1804.
[Full Text]